Manufacturers Life Insurance Company, The Aurinia Pharmaceuticals Inc. Transaction History

Manufacturers Life Insurance Company, The

$108 Billion
Q3 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 47,550 shares of AUPH stock, worth $386,105. This represents 0.0% of its overall portfolio holdings.

Number of Shares

47,550

Previous 52,747 9.85%

Holding current value

$386,105

Previous $301,000 15.61%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$5.32 - $7.33 $27,648 - $38,094	-5,197 Reduced 9.85%	47,550 $348,000
Q2 2024 Aug 14, 2024	BUY	$4.81 - $5.78 $23,126 - $27,790	4,808 Added 10.03%	52,747 $301,000
Q1 2024 May 14, 2024	SELL	$4.93 - $9.31 $8,109 - $15,314	-1,645 Reduced 3.32%	47,939 $240,000
Q4 2023 Feb 13, 2024	SELL	$7.13 - $9.49 $6,580 - $8,759	-923 Reduced 1.83%	49,584 $445,000
Q3 2023 Nov 15, 2023	BUY	$7.77 - $12.27 $240 - $380	31 Added 0.06%	50,507 $392,000
Q2 2023 Aug 11, 2023	BUY	$8.96 - $11.69 $9,085 - $11,853	1,014 Added 2.05%	50,476 $488,000
Q4 2022 Aug 11, 2023	SELL	$4.11 - $8.14 $1,101 - $2,181	-268 Reduced 0.54%	49,462 $213,000
Q4 2022 Feb 13, 2023	SELL	$4.11 - $8.14 $1,101 - $2,181	-268 Reduced 0.54%	49,462 $213,000
Q3 2022 Aug 11, 2023	SELL	$6.66 - $12.39 $5,940 - $11,051	-892 Reduced 1.76%	49,730 $373,000
Q3 2022 Nov 03, 2022	SELL	$6.66 - $12.39 $5,940 - $11,051	-892 Reduced 1.76%	49,730 $374,000
Q2 2022 Aug 11, 2023	BUY	$8.95 - $12.8 $10,382 - $14,848	1,160 Added 2.35%	50,622 $508,000
Q2 2022 Aug 15, 2022	BUY	$8.95 - $12.8 $453,066 - $647,961	50,622 New	50,622 $509,000
Q3 2021 Nov 12, 2021	SELL	$10.93 - $23.55 $1.2 Million - $2.59 Million	-109,845 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$10.0 - $14.52 $47,660 - $69,202	-4,766 Reduced 4.16%	109,845 $1.77 Million
Q1 2021 May 03, 2021	SELL	$12.3 - $18.73 $34,440 - $52,444	-2,800 Reduced 2.38%	114,611 $1.87 Million
Q4 2020 Feb 12, 2021	SELL	$12.94 - $16.05 $13,185 - $16,354	-1,019 Reduced 0.86%	117,411 $2.06 Million
Q3 2020 Nov 09, 2020	BUY	$13.19 - $16.66 $166,088 - $209,782	12,592 Added 11.9%	118,430 $2.32 Million
Q2 2020 Aug 10, 2020	BUY	$14.12 - $18.33 $1.49 Million - $1.94 Million	105,838 New	105,838 $2 Million

Others Institutions Holding AUPH

# of Institutions

209

Shares Held

58.7M

Call Options Held

1.14M

Put Options Held

1.51M

View Full List

About Aurinia Pharmaceuticals Inc.

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.15B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

More about AUPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Account

Manufacturers Life Insurance Company, The Aurinia Pharmaceuticals Inc. Transaction History